Biosensor technology company Profusa Inc announced that revenue from its Lumee oxygen monitoring product in the European market is expected to receive substantial support starting from the second quarter of 2026.
Show original
This development marks a key step for the company in advancing the commercialization of implantable biosensors, injecting strong momentum for future performance growth.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
LME copper futures closed up by $39, at $13,344 per ton.
华尔街见闻•2026/02/27 17:55
UBS: The US dollar faces asymmetric structural downside risks
华尔街见闻•2026/02/27 17:25
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$65,659.33
-1.75%
Ethereum
ETH
$1,931.23
-2.93%
Tether USDt
USDT
$0.9999
-0.02%
BNB
BNB
$610.86
-0.95%
XRP
XRP
$1.36
-2.23%
USDC
USDC
$1.0000
-0.01%
Solana
SOL
$81.65
-3.94%
TRON
TRX
$0.2823
-1.04%
Dogecoin
DOGE
$0.09367
-2.27%
Cardano
ADA
$0.2775
-2.13%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now